MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 172 filers reported holding MANNKIND CORP in Q4 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $399,000 | +25.9% | 627,211 | +22.9% | 0.00% | – |
Q3 2016 | $317,000 | -60.5% | 510,528 | -26.2% | 0.00% | -100.0% |
Q2 2016 | $802,000 | +147.5% | 691,375 | +243.1% | 0.00% | – |
Q1 2016 | $324,000 | -81.1% | 201,519 | -82.9% | 0.00% | -100.0% |
Q4 2015 | $1,712,000 | -62.8% | 1,180,704 | -17.7% | 0.00% | -75.0% |
Q3 2015 | $4,608,000 | -41.2% | 1,435,496 | +4.2% | 0.00% | -33.3% |
Q2 2015 | $7,841,000 | -8.7% | 1,378,010 | -16.6% | 0.01% | 0.0% |
Q1 2015 | $8,588,000 | -0.6% | 1,651,449 | -0.3% | 0.01% | 0.0% |
Q4 2014 | $8,639,000 | -14.0% | 1,656,607 | -2.5% | 0.01% | -14.3% |
Q3 2014 | $10,042,000 | -28.0% | 1,699,082 | +34.0% | 0.01% | -30.0% |
Q2 2014 | $13,938,000 | +268.3% | 1,268,218 | +34.7% | 0.01% | +233.3% |
Q1 2014 | $3,784,000 | +10.3% | 941,289 | +42.9% | 0.00% | +50.0% |
Q4 2013 | $3,431,000 | -9.7% | 658,629 | -1.2% | 0.00% | -33.3% |
Q3 2013 | $3,798,000 | -4.9% | 666,322 | +8.4% | 0.00% | 0.0% |
Q2 2013 | $3,994,000 | – | 614,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greywolf Capital Management LP | 7,206,570 | $37,582,000 | 6.66% |
AYM CAPITAL, LLC | 1,417,300 | $7,392,000 | 5.50% |
AYM CAPITAL, LLC | 655,000 | $3,416,000 | 2.54% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 1,810,250 | $9,440,000 | 2.51% |
Beach Point Capital Management LP | 1,902,100 | $9,919,000 | 2.37% |
Cohen Capital Management, Inc. | 503,000 | $2,623,000 | 0.68% |
Tourbillon Capital Partners, L.P. | 3,300,000 | $17,210,000 | 0.46% |
EQUITEC SPECIALISTS, LLC | 288,700 | $1,504,000 | 0.39% |
Old West Investment Management, LLC | 116,676 | $608,000 | 0.38% |
Adamant Biomedical Investments AG | 300,000 | $1,564,000 | 0.37% |